226 related articles for article (PubMed ID: 17656111)
1. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
[TBL] [Abstract][Full Text] [Related]
2. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
[TBL] [Abstract][Full Text] [Related]
3. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
[TBL] [Abstract][Full Text] [Related]
4. Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents.
Burnouf T; Sayed MA; Radosevich M; El-Ekiaby M
Anal Biochem; 2009 Jun; 389(1):69-73. PubMed ID: 19303391
[TBL] [Abstract][Full Text] [Related]
5. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.
Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH
Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375
[TBL] [Abstract][Full Text] [Related]
6. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system.
El-Ekiaby M; Sayed MA; Caron C; Burnouf S; El-Sharkawy N; Goubran H; Radosevich M; Goudemand J; Blum D; de Melo L; Soulié V; Adam J; Burnouf T
Transfus Med; 2010 Feb; 20(1):48-61. PubMed ID: 19778318
[TBL] [Abstract][Full Text] [Related]
7. Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products.
Roberts P
Biologicals; 2000 Mar; 28(1):29-32. PubMed ID: 10799053
[TBL] [Abstract][Full Text] [Related]
8. Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII.
Roberts PL
Biologicals; 2008 Sep; 36(5):330-5. PubMed ID: 18674928
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom.
Segura A; León G; Su CY; Gutiérrez JM; Burnouf T
Biologicals; 2009 Oct; 37(5):306-12. PubMed ID: 19540775
[TBL] [Abstract][Full Text] [Related]
10. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
[TBL] [Abstract][Full Text] [Related]
11. TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.
Chou ML; Burnouf T; Chang SP; Hung TC; Lin CC; Richardson CD; Lin LT
PLoS One; 2015; 10(2):e0117800. PubMed ID: 25658612
[TBL] [Abstract][Full Text] [Related]
12. [Virus inactivated plasma].
Köhler M; Wieding JU
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():73-6. PubMed ID: 8000259
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary results of a prospective randomized clinical study on the comparison of solvent- and detergent-inactivated plasma (SDP-TNBT/Triton X-100) and untreated fresh-frozen plasma].
Mortelmans Y; Beck KH; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():419-21. PubMed ID: 9480136
[TBL] [Abstract][Full Text] [Related]
14. [Solvent-detergent viral inactivation of minipools of plasma for transfusion, cryoprecipitate and cryo-poor plasma in single-use bag systems].
Burnouf T; Goubran HA; Radosevich M; El-Ekiaby M
Transfus Clin Biol; 2008 Jun; 15(3):129-34. PubMed ID: 18538608
[TBL] [Abstract][Full Text] [Related]
15. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors.
Burnouf T; Tseng YH; Kuo YP; Su CY
Transfusion; 2008 Jun; 48(6):1090-8. PubMed ID: 18373502
[TBL] [Abstract][Full Text] [Related]
16. Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent--detergent method.
Strancar A; Raspor P; Schwinn H; Schütz R; Josic D
J Chromatogr A; 1994 Jan; 658(2):475-81. PubMed ID: 8118553
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
Gürtler L
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
[TBL] [Abstract][Full Text] [Related]
18. Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria.
Chou ML; Wu YW; Su CY; Lee LW; Burnouf T
Vox Sang; 2012 May; 102(4):277-84. PubMed ID: 22092109
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation.
Conley L; Tao Y; Henry A; Koepf E; Cecchini D; Pieracci J; Ghose S
Biotechnol Bioeng; 2017 Apr; 114(4):813-820. PubMed ID: 27800626
[TBL] [Abstract][Full Text] [Related]
20. Effect of increasing concentrations of nonionic detergent Triton X-100 on solubilization and structure of rat liver and adipose plasma membranes.
Yegutkin GG
Membr Cell Biol; 1997; 10(5):515-20. PubMed ID: 9225255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
